News

The ISTT responds to the ECJ Ruling that CRISPR/Cas9 should be regulated as GMO

Published Wednesday, August 15, 2018

The Board of Directors of the International Society for Transgenic Technology (ISTT) has the following comment on the ruling of the European Court of Justice (ECJ), which requires any that genome-edited organism shall be treated as GMO within the meaning of the European GMO Directive.

The ISTT, a scientific society representing the largest group of experts in the field of genome modification in animals, is surprised and disappointed that the court decided to focus on the method and not the product of genome editing and thus did not follow the recommendation of the court's Advocate General.

more»

John D. Biggers, 1923-2018

Published Wednesday, April 18, 2018
John D. Biggers, Physiologist/embryologist, passed away recently in Massachusetts. Here is a memorial from Lluis Montoliu: Dear colleagues, Just a short message to make you aware about the recent passing of John D. Biggers, on April 7, 2018. If you don’t know who this reproductive physiologist was, you should ask yourself who do you think more»

Association for Responsible Research and Innovation in Genome Editing (ARRIGE) Launched

Published Friday, March 30, 2018
The Association for Responsible Research and Innovation in Genome Editing" was launched on 23 March, 2018 to promote a global governance of genome editing technologies, to promote the responsible use of the these techniques and tools, taking into account all associated ethics issues as well, in relation to their application to human beings, to animals, to more»

TT2019 Awarded to Kobe, Japan

Published Thursday, August 17, 2017

The ISTT Board of Directors has chosen Kobe Japan to host TT2019, the 15th Transgenic Technology meeting, April 2019.

more»

CRISPR Gene Editing of Human Embryos

Published Friday, August 4, 2017

In a collaborative effort of USA, South Korean and Chinese laboratories, the authors describe the correction of a mutation in the MYBPC3 gene associated with hypertrophic cardiomyopathy, through gene-editing, using CRISPR tools. (Nature article detailing results).

more»

Mario Capecchi, Nobel Laureate, to be awarded the ISTT Prize at TT2017

Published Friday, November 4, 2016

The International Society for Transgenic Technologies (ISTT, Inc.) is delighted to announce that the 11th ISTT Prize will be awarded to Dr. Mario Capecchi for his seminal work on homologous recombination in embryonic stem cells, for which he was awarded the Nobel Prize in 2007.  The ISTT Prize is awarded to investigators who have made outstanding contributions to the field of transgenic technologies. 

more»